
Precigen PGEN
$ 4.06
2.92%
Annual report 2025
added 03-25-2026
Precigen DIO Ratio 2011-2026 | PGEN
Annual DIO Ratio Precigen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 95.7 | 124 | 119 | 125 | 152 | 489 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 489 | 95.7 | 184 |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
AstraZeneca PLC
AZN
|
206 | - | - | $ 96.9 B | ||
|
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
125 | - | - | $ 546 M | ||
|
CASI Pharmaceuticals
CASI
|
47.4 | - | - | $ 35.4 M | ||
|
Завод ДИОД
DIOD
|
768 | - | - | - | ||
|
Фармсинтез
LIFE
|
120 | - | - | - | ||
|
Teligent, Inc.
TLGT
|
198 | - | -13.85 % | $ 16.1 M | ||
|
AbbVie
ABBV
|
91.6 | $ 208.7 | -0.07 % | $ 369 B |